Antibacterial Drugs Today
Autor A. P. Ball, J.A. Gray, J.McC. Murdochen Limba Engleză Paperback – 31 mai 1979
Preț: 353.46 lei
Preț vechi: 372.07 lei
-5% Nou
Puncte Express: 530
Preț estimativ în valută:
67.64€ • 71.16$ • 56.44£
67.64€ • 71.16$ • 56.44£
Carte tipărită la comandă
Livrare economică 09-23 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780852005057
ISBN-10: 0852005059
Pagini: 163
Ilustrații: 163 p.
Dimensiuni: 170 x 244 x 10 mm
Greutate: 0.3 kg
Ediția:1978
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
ISBN-10: 0852005059
Pagini: 163
Ilustrații: 163 p.
Dimensiuni: 170 x 244 x 10 mm
Greutate: 0.3 kg
Ediția:1978
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
1. Antibacterial Drugs.- 1.1 Mechanisms of Action.- 1.2 Side Effects and Toxicity.- 2. The Sulphonamides.- 2.1 Antibacterial Activity.- 2.2 Mode of Antibacterial Action.- 2.3 Pharmacology.- 2.4 Therapeutic Indications.- 2.5 Dosage.- 2.6 Side Effects and Toxicity.- 2.7 Drug Interactions.- 3. The Natural Penicillins — Benzylpenicillin (Penicillin G) and Phenoxymethylpenicillin (Penicillin V).- 3.1 Physicochemical Properties.- 3.2 Mode of Antibacterial Action.- 3.3 Antibacterial Activity.- 3.4 Pharmacology.- 3.5 Therapeutic Indications.- 3.6 Dosage.- 3.7 Side Effects and Toxicity.- 4. The Semi-synthetic Penicillins.- 4.1 Phenoxypenicillins.- 4.2 Penicillinase Resistant Penicillins.- 4.3 Other Penicillinase Resistant Penicillins.- 4.4 Broad Spectrum Penicillins.- 5. Mecillinam and Pivmecillinam.- 5.1 Antibacterial Activity.- 5.2 Mode of Action.- 5.3 Pharmacology.- 5.4 Indications.- 5.5. Dosage.- 5.6 Side Effects.- 6. Co-trimoxazole (Trimethoprim-sulphamethoxazole).- 6.1 Antibacterial Activity.- 6.2 Mode of Action.- 6.3 Pharmacology.- 6.4 Indications.- 6.5 Dosage.- 6.6 Contraindications.- 6.7 Side Effects and Toxicity.- 6.8 Drug Interactions.- 7. Chloramphenicol.- 7.1 Therapeutic Indications.- 8. The Tetracyclines.- 8.1 Antibacterial Activity.- 8.2 Pharmacology.- 8.3 Therapeutic Indications.- 8.4 Side Effects and Toxicity.- 9. The Macrolides.- 9.1 Erythromycin.- 9.2 Spiramycin and Triacetyloleandomycin.- 10. Lincomycin and Clindamycin.- 10.1 Mode of Action.- 10.2 Antibacterial Activity.- 10.3 Pharmacology.- 10.4 Therapeutic Indications.- 10.5 Dosage.- 10.6 Side Effects and Toxicity.- 11. Fusidic Acid (Sodium Fusidate).- 11.1 Mode of Action.- 11.2 Antibacterial Activity.- 11.3 Pharmacology.- 11.4 Therapeutic Indications.- 11.5 Dosage.- 11.6 Side Effects and Toxicity.- 12.The Urinary Antiseptics.- 12.1 Nitrofurantoin.- 12.2 Nalidixic Acid.- 12.3 Oxolinic Acid.- 13. Cephalosporins.- 13.1 Cephaloridine.- 13.2 Cephalothin.- 13.3 Cephalexin.- 13.4 Cephradine.- 13.5 The Cephamycins.- 13.6 Newer Cephalosporin Derivatives.- 14. Peptide Antibiotics (Polymyxin B and Polymyxin E).- 14.1 Antibacterial Activity.- 14.2 Pharmacology.- 14.3 Therapeutic Indications and Dosage.- 14.4 Side Effects and Toxicity.- 15. The Aminoglycosides.- 15.1 Streptomycin.- 15.2 Kanamycin.- 15.3 Gentamicin.- 15.4 Tobramycin.- 15.5 Neomycin, Framycetin and Paromomycin.- 15.6 Newer Aminoglycosides.- 16. Metronidazole.- 16.1 Antibacterial Activity.- 16.2 Mode of Action.- 16.3 Pharmacology.- 16.4 Therapeutic Indications $.- 16.5 Dosage.- 16.6 Toxicity and Interactions.- 17. Antituberculosis Drugs.- 17.1 Isoniazid.- 17.2 Rifampicin.- 17.3 Ethambutol.- 17.4 Streptomycin.- 17.5 Para-aminosalicylic Acid (PAS).- 17.6 Capreomycin.- 17.7 Other Drugs.- 18. Chemotherapy of Gram-negative Bacillary Infections.- 18.1 General Considerations.- 18.2 Organisms.- 18.3 Choice of Antibacterial Agents.- 18.4 Routes of Administration and Duration of Therapy.- 18.5 Precautions.- 18.6 Specific Infections.- 19. Anaerobic Infections.- 19.1 Clostridial Infections.- 19.2 Non-clostridial Anaerobic Infections.- 20. Antibacterial Therapy in Renal and Hepatic Disease.- 20.1 Renal Disease.- 20.2 Hepatic Disease.- 21. Antibacterial Therapy in Infants and Children.- 21.1 General Considerations.- 21.2 Dosage.- 21.3 Clinical Pharmacology in Premature Infants and the Newborn.- 21.4 Special Considerations with Individual Drugs.- 21.5 Specific Infections in Infants.- 22. Antibacterial Therapy in the Elderly.- 22.1 General Principles.- 22.2 Urinary Tract Infection.- 22.3 Chest Infection.- 22.4 Skin and Soft TissueInfection.- 23. Antibacterial Drugs in Obstetrics and Gynaecology.- 23.1 Obstetrics.- 23.2 Gynaecology.- 24. Surgical Infections.- 24.1 Prophylaxis of Surgical Infection.- 24.2 Pyrexia Following Surgery.- 25. Opportunistic Infection.- 25.1 Exogenous Opportunistic Infection.- 25.2 Endogenous Opportunistic Infection.- 25.3 Bacteraemia.- 25.4 Management of Opportunistic Infection.- 26. The Management of Tuberculosis.- References.